Bronchitol, Under Phase 3 Clinical Trials
Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics on April 22, 2006
Pharmaxis Ltd will be commencing its Phase 3 clinical trials for Bronchitol, testing its safety and effectivity against bronchiectasis, a lung disease characterized by abnormal destruction and dilation of the large airways.
"This pivotal trial for Bronchitol is the final step before registration in Australia, New Zealand and the European Union.
When complete, the results of the study should provide sufficient data for a marketing application to be lodged."
Bronchitol is a is medication being developed not only for the treatment of chronic obstructive pulmonary disease such as bronchoectasis and chronic bronchitis, but also against cystic fibrosis. The drug is produced from mannitol, a naturally occuring sugar, and comes as inhalable dry powder that can be administered via a hand-held, pocket-sized device.
[Photo: Medline Plus]
When complete, the results of the study should provide sufficient data for a marketing application to be lodged."
Permalink: Bronchitol, Under Phase 3 Clinical Trials
Tags: bronchitis clinical biotech phase trials phase+clinical clinical+trials under+phase
Vote for Bronchitol, Under Phase 3 Clinical Trials:
|
Rating: 8.83 out of 6 vote(s) cast.
|
Response from:
Rita
(06/28/07 10:10am)
Good news!
Response from:
erin
(05/23/08 1:42am)
does this help with asbestosis related bronchiectasis .???
Response from:
Robert
(05/26/08 9:48am)
This is the best product I have used for my bronchiectasis
Response from:
Oyebode Olatade
(08/07/08 11:53am)
'Am a Nigerian suffering from Brochiectasis. Is it possible to have access to such drug. 'll be grateful to recieve a response from you. Bode
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells